TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11527638

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 7788

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7788
Study: 9307902

Group type: EXPERIMENTAL
Intervention: Three‐directional MR velocity mapping
Number of subjects: 28
Study: 8364132

Group type: EXPERIMENTAL
Intervention: 60 mg/day ZnSO4
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 200 mg/day ZnSO4
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 3538460

Group type: EXPERIMENTAL
Intervention: misonidazole (1 g/m2 body surface)
Number of subjects: 91

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 91
Study: 29728296

Group type: EXPERIMENTAL
Intervention: Animated cartoon
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Buzzy® device
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination of Buzzy® and animated cartoon
Number of subjects: 150

Group type: COMPARATOR
Intervention: No method (control group)
Number of subjects: 150
Study: 25370571

Group type: EXPERIMENTAL
Intervention: Psychological intervention (cognitive behavioural therapy combined with counselling techniques)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study: 25278107

Group type: COMPARATOR
Intervention: Social exclusion (via writing prime)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social exclusion (via Cyberball)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disease threat prime
Number of subjects: 0

Group type: COMPARATOR
Intervention: General negative affective state prime
Number of subjects: 0
Study: 21705786

Group type: EXPERIMENTAL
Intervention: Obese participants (BMI categorized as obese)
Number of subjects: 3207

Group type: COMPARATOR
Intervention: Normal weight participants (BMI categorized as normal weight)
Number of subjects: 3207

Group type: EXPERIMENTAL
Intervention: Obese men (BMI categorized as obese)
Number of subjects: 3207

Group type: COMPARATOR
Intervention: Normal weight men (BMI categorized as normal weight)
Number of subjects: 3207

Group type: EXPERIMENTAL
Intervention: Adjusted analysis for obesity effects
Number of subjects: 3207
Study: 20175096

Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 0
Study: 18945365

Group type: EXPERIMENTAL
Intervention: Hausa version of the Ibadan Knee/Hip Osteoarthritis Outcome Measure (IKHOAM)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale for pain intensity
Number of subjects: 67
Study: 16148467

Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation + Automatic Tube Compensation (PAV+ATC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation (PAV)
Number of subjects: 12
Study: 14726838

Group type: EXPERIMENTAL
Intervention: Sodium fondaparinux
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low‐molecular‐weight heparin
Number of subjects: 0
Study: 10658543

Group type: EXPERIMENTAL
Intervention: 50 ppm toluene for 3 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham exposure (filtered air) for 3 hours
Number of subjects: 0
Study: 8911981

Group type: EXPERIMENTAL
Intervention: Glimepiride (5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glibenclamide (5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2476641

Group type: EXPERIMENTAL
Intervention: Platelet activating factor (PAF) supplementation (0.186, 0.93, or 1.49 mumol/1)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Control (0 mumol/1 PAF)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Platelet activating factor (PAF) supplementation
Number of subjects: 351
Study: 827759

Group type: EXPERIMENTAL
Intervention: amitriptyline (Elavil)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: methylphenidate (Ritalin)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 31178508

Group type: EXPERIMENTAL
Intervention: Kikyo-to (KKT) 2.5 g
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Kikyo-to (KKT)
Number of subjects: 70
Study: 29217521

Group type: EXPERIMENTAL
Intervention: Laser Balloon (LB)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Wide-Area Circumferential Radiofrequency Ablation (RF)
Number of subjects: 134
Study: 25656334

Group type: EXPERIMENTAL
Intervention: Guided self-help (n = 27)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard information and support (Control group, n = 27)
Number of subjects: 54
Study: 23443723

Group type: EXPERIMENTAL
Intervention: Sildenafil 100mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 21485567

Group type: EXPERIMENTAL
Intervention: Clavicular hook plate fixation (Group A)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Coracoid transplantation (Group B)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Clavicular hook plate fixation combined with modified dynamic muscle transfer (Group C)
Number of subjects: 65
Study: 19688837

Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.3 mg/kg body weight, maximum 10 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 22316568

Group type: EXPERIMENTAL
Intervention: Negative symptoms (measured by PANSS negative factor)
Number of subjects: 1447

Group type: EXPERIMENTAL
Intervention: Negative symptoms (improvement)
Number of subjects: 1447

Group type: EXPERIMENTAL
Intervention: Functional outcomes (measured by Calgary Depression Rating Scale and select items from Heinrich's and Lehman's Quality of Life Scales)
Number of subjects: 1447
Study: 15885227

Group type: EXPERIMENTAL
Intervention: Normothermic blood
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hypothermic crystalloid
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hypothermic blood
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hypothermic groups
Number of subjects: 42
Study: 12358241

Group type: EXPERIMENTAL
Intervention: Endoscopic hemoclip
Number of subjects: 80

Group type: COMPARATOR
Intervention: Heater probe thermocoagulation
Number of subjects: 80
Study: 9695587

Group type: EXPERIMENTAL
Intervention: Adjuvant laferon therapy (intraperitoneal and systemic administration)
Number of subjects: 0
Study: 8077355

Group type: COMPARATOR
Intervention: 0.2 mg/kg L-692,429, i.v. preceded by 4 days of prednisolone (20 mg, orally, three times daily)
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0.75 mg/kg L-692,429 preceded by prednisolone only
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0.2 mg/kg L-692,429 in the absence of steroid
Number of subjects: 9
Study: 2491941

Group type: EXPERIMENTAL
Intervention: (-)-deprenyl (30 mg/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 58269

Group type: EXPERIMENTAL
Intervention: Screening for hypertension
Number of subjects: 2420

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 2420

Group type: COMPARATOR
Intervention: Blood-pressure levels in screening population
Number of subjects: 2420

Group type: COMPARATOR
Intervention: General practitioner visits
Number of subjects: 2420
Study: 31068063

Group type: EXPERIMENTAL
Intervention: VTC-administered ADAS-cog
Number of subjects: 73

Group type: COMPARATOR
Intervention: FTF-administered ADAS-cog
Number of subjects: 73
Study: 29357947

Group type: EXPERIMENTAL
Intervention: Auto-adjusting CPAP (APAP) + standard care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 60
Study: 27590681

Group type: EXPERIMENTAL
Intervention: Exercise training intervention (3 times per week for 6 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group without exercise
Number of subjects: 30
Study: 24258468

Group type: COMPARATOR
Intervention: Strefen lozenges
Number of subjects: 320

Group type: COMPARATOR
Intervention: Siccoral spray
Number of subjects: 320

Group type: COMPARATOR
Intervention: Stomatovis gargle
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 320
Study: 22023081

Group type: EXPERIMENTAL
Intervention: Haberlea extract (3% in cream)
Number of subjects: 20
Study: 20075143

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg)
Number of subjects: 14
Study: 18174071

Group type: EXPERIMENTAL
Intervention: Midpalatal implants
Number of subjects: 51

Group type: COMPARATOR
Intervention: Headgear
Number of subjects: 51
Study: 15767770

Group type: EXPERIMENTAL
Intervention: Ammonium hydroxide (AM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dimethylamine (DMA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Trimethylamine (TMA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Acetic acid (AA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SLS combined with biogenic amines
Number of subjects: 20
Study: 14641968

Group type: EXPERIMENTAL
Intervention: Olestra
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise intervention study
Number of subjects: 14
Study: 10622480

Group type: EXPERIMENTAL
Intervention: Closed-wedge osteotomy (HTO, n 16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Open-wedge osteotomy by hemicallotasis (HCO, n 19)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Closed-wedge osteotomy (HTO)
Number of subjects: 33
Study: 8963856

Group type: EXPERIMENTAL
Intervention: Combined surgery (CS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sequential surgery (SS)
Number of subjects: 26
Study: 2045624

Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/Kg iv)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (60 mg po)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: PD + GHRH (60 mg PD orally 60 min before GHRH)
Number of subjects: 31
Study: 7389390

Group type: EXPERIMENTAL
Intervention: Single night-time dose of chlordiazepoxide (5 mg) and amitriptyline (12.5 mg) - 3 capsules as a single dose at night
Number of subjects: 80

Group type: COMPARATOR
Intervention: Divided daily dosage regimen of chlordiazepoxide (5 mg) and amitriptyline (12.5 mg) - 1 capsule 3-times daily
Number of subjects: 80
Study: 31813044

Group type: EXPERIMENTAL
Intervention: HIGH (1 hour high-intensity interval running session, 6×5 min at 90% VO2peak)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: LOW (1 hour low-intensity running session, 60 min at 45% VO2peak)
Number of subjects: 8

Group type: COMPARATOR
Intervention: CON (no exercise)
Number of subjects: 8
Study: 31608830

Group type: EXPERIMENTAL
Intervention: Sleep hygiene education (EG, n = 17)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (CG, n = 12)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sleep hygiene education (EG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 29
Study: 28084606

Group type: EXPERIMENTAL
Intervention: Mailed survey with phone follow-up
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Interactive voice response (IVR) followed by mail
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Email linked to web-based survey with mail follow-up
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Email linked to web-based survey followed by IVR
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Non-Hispanic whites
Number of subjects: 4000

Group type: COMPARATOR
Intervention: English speakers
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Higher socioeconomic status
Number of subjects: 4000
Study: 25873137

Group type: EXPERIMENTAL
Intervention: internet-based cognitive behavior therapy (iCBT)
Number of subjects: 500

Group type: COMPARATOR
Intervention: standard of care
Number of subjects: 500
Study: 24163364

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.5 mg/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 21318572

Group type: EXPERIMENTAL
Intervention: Romiplostim (1 μg/kg/week, escalated to 5 μg/kg/week, tapered over 12 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20532105

Group type: COMPARATOR
Intervention: Oral midazolam 0.5 mg/kg mixed with ibuprofen 10 mg/kg (Group M)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg/kg mixed with ibuprofen 10 mg/kg and ketamine 2 mg/kg (Group KM)
Number of subjects: 92
Study: 17004125

Group type: EXPERIMENTAL
Intervention: Non-compliance detection method
Number of subjects: 0

Group type: COMPARATOR
Intervention: PK cleaned dataset
Number of subjects: 0
Study: 14684640

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11116493

Group type: EXPERIMENTAL
Intervention: Hand-held NasOral System (NOS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nose mask fastened by rubber band
Number of subjects: 50

Group type: COMPARATOR
Intervention: Face mask
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hand-held NOS
Number of subjects: 50
Study: 9201140

Group type: EXPERIMENTAL
Intervention: IVIG 250 mg/kg/day for 2 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IVIG 400 mg/kg/day for 2 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IVIG 500 mg/kg/day for 2 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: IVIG 1 g/kg/day for 2 days (control)
Number of subjects: 24
Study: 1488936

Group type: EXPERIMENTAL
Intervention: Role play with a confederate and visual cues
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Role play with a confederate and no cues
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Role play with a confederate and visual plus olfactory cues
Number of subjects: 56

Group type: COMPARATOR
Intervention: Confederate absent with no cues
Number of subjects: 56

Group type: COMPARATOR
Intervention: Confederate absent with visual cues
Number of subjects: 56

Group type: COMPARATOR
Intervention: Confederate absent with visual plus olfactory cues
Number of subjects: 56
Study: 4022376

Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31445626

Group type: EXPERIMENTAL
Intervention: Colloidal silver-impregnated wipe with sterile screw-top urine collection container (Group B)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Castile-soap wipe with sterile screw-top urine collection container (Group A)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Colloidal silver-impregnated wipe with sterile urine-collection funnel (Group D)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Castile-soap wipe with sterile urine-collection funnel (Group C)
Number of subjects: 223
Study: 29406431

Group type: EXPERIMENTAL
Intervention: Immediate HIV assisted partner services (APS)
Number of subjects: 1119

Group type: COMPARATOR
Intervention: Delayed HIV assisted partner services (APS) for 6 weeks
Number of subjects: 1119
Study: 27632848

Group type: EXPERIMENTAL
Intervention: Strength‐ and plyometric‐training group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Strength‐training group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Plyometric‐training group
Number of subjects: 40
Study: 24526895

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic Intervention Module (PIM), n = 90, six therapy sessions over two months.
Number of subjects: 173

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU), n = 83.
Number of subjects: 173
Study: 23409602

Group type: EXPERIMENTAL
Intervention: Within-trials change group (target velocity changed from 4 to 8 m/sec during the trial)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Inter-trials change group (initial velocity remained constant at 4 or 8 m/sec)
Number of subjects: 14
Study: 20102918

Group type: EXPERIMENTAL
Intervention: Red yeast rice 2,400 mg twice daily
Number of subjects: 43

Group type: COMPARATOR
Intervention: Pravastatin 20 mg twice daily
Number of subjects: 43
Study: 18545692

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 414
Study: 15845714

Group type: EXPERIMENTAL
Intervention: CSE (combined spinal-epidural technique)
Number of subjects: 60

Group type: COMPARATOR
Intervention: SSS (single-shot spinal technique)
Number of subjects: 60
Study: 12460724

Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response in people with diabetes and amputation
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response in smokers
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response in vasodilator users
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response across skin pigmentation
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response across age
Number of subjects: 88
Study: 10027684

Group type: EXPERIMENTAL
Intervention: Diary card measure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Symptom question in a gastrointestinal symptom questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Symptom severity rating made by the investigator
Number of subjects: 0
Study: 7608363

Group type: EXPERIMENTAL
Intervention: Notebook training
Number of subjects: 8

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 8
Study: 2198381

Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg orally
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 676877

Group type: EXPERIMENTAL
Intervention: Gentamicin (1.0 mg/kg body-weight)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sisomicin (1.0 mg/kg body-weight)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amikacin (one-hour constant infusion)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tobramycin (1.0 mg/kg body-weight)
Number of subjects: 12
Study: 31074198

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham-IMT
Number of subjects: 59
Study: 30359890

Group type: EXPERIMENTAL
Intervention: Social feedback that one scene was not experienced
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Objective false evidence that one of the scenes was not shown
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both social feedback and objective false evidence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no manipulation)
Number of subjects: 0
Study: 28278309

Group type: EXPERIMENTAL
Intervention: High adherence to the Mediterranean diet (>35/55 score)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Medium adherence to the Mediterranean diet
Number of subjects: 343

Group type: COMPARATOR
Intervention: Low adherence to the Mediterranean diet
Number of subjects: 343
Study: 24909787

Group type: EXPERIMENTAL
Intervention: Intensive residential treatment (IRT)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Intensive residential treatment (IRT) responders
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Intensive residential treatment (IRT) participants who achieved wellness
Number of subjects: 281
Study: 22750086

Group type: EXPERIMENTAL
Intervention: Increased sample size to 3000 and follow-up for one year after recruitment
Number of subjects: 3000
Study: 21041811

Group type: EXPERIMENTAL
Intervention: Diet rich in pulses and wholegrains (2 serves of pulses and 4 serves of wholegrain foods per day)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control diet (not specified)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 113
Study: 17413195

Group type: EXPERIMENTAL
Intervention: Gastric lavage with mother's milk (BML group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nil per orally (NPO group)
Number of subjects: 80
Study: 16306540

Group type: COMPARATOR
Intervention: DASH diet
Number of subjects: 116

Group type: COMPARATOR
Intervention: Weight-reducing diet
Number of subjects: 116
Study: 12471293

Group type: EXPERIMENTAL
Intervention: Active warm-up
Number of subjects: 43

Group type: COMPARATOR
Intervention: High-heat passive warm-up before eccentric exercise
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Eccentric exercise without warm-up
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Low-heat passive warm-up
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: High-heat passive warm-up without eccentric exercise
Number of subjects: 43
Study: 9836546

Group type: EXPERIMENTAL
Intervention: pT1a tumors
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: pT1b tumors
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: pT1c tumors
Number of subjects: 124

Group type: COMPARATOR
Intervention: Absence of CIS in the tumor
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Presence of CIS in the tumor
Number of subjects: 124

Group type: COMPARATOR
Intervention: Absence of CIS in biopsy specimens
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Presence of CIS in biopsy specimens
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Combination of pT1c and CIS
Number of subjects: 124
Study: 7926138

Group type: EXPERIMENTAL
Intervention: Veralipride 100 mg/d
Number of subjects: 40
Study: 2913138

Group type: EXPERIMENTAL
Intervention: Active treatment with cat-dander extracts for 2 years (group A)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Active treatment with cat-dander extracts for 1 year (group B)
Number of subjects: 35
Study: 4883848

Group type: EXPERIMENTAL
Intervention: Preseasonal Allpyral
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Depo‐Medrone
Number of subjects: 300

Group type: COMPARATOR
Intervention: Coseasonal Allpyral
Number of subjects: 300
Study: 387054

Group type: EXPERIMENTAL
Intervention: Nitrous oxide 50% in oxygen (Entonox) during chest physiotherapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oxygen 100% during chest physiotherapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nitrous oxide 50% in oxygen (Entonox) without chest physiotherapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Withdrawal of nitrous oxide
Number of subjects: 12
Study: 31030188

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 79
Study: 27388589

Group type: EXPERIMENTAL
Intervention: Liquid levothyroxine formulation
Number of subjects: 155

Group type: COMPARATOR
Intervention: Tablet levothyroxine formulation
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Levothyroxine replacement therapy (both formulations)
Number of subjects: 155